Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples
Summary
Tasso , a Seattle-based startup that is developing an at-home blood sample collection device, announced Tuesday it has raised $6.1 million from investors. Tasso’s funding announcement didn’t mention whether it’s seeking FDA clearance to begin marketing the device in the U.S. We’ve reached out to the company for comment. Tasso OnDemand, which is approximately the size of a small stack of poker chips, is designed to stick to a patient’s upper arm and collect a blood sample in about two minutes, the startup says. Tasso moved its headquarters to Seattle in 2015, not long after Xconomy reported on the company and its partnership with Pleasanton, CA-based GenTegra. Other companies developing new devices for collecting blood samples and other biological fluids include Cambridge, MA-based Seventh Sense Biosystems and Athelas, which is headquartered in Mountain View, CA.
Funding
Review available funding amount, funding date, investors, and linked company information related to Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples in the interactive ISVWorld profile.
Classifications
AskAI Classifications
LabelsLinked Companies
